WIXELA INHUB

ਉਤਪਾਦ ਝਲਕ

About WIXELA INHUB

WIXELA INHUB is a prescription medication that combines two active ingredients, SALMETEROL (SALMETEROL XINAFOATE) and FLUTICASONE PROPIONATE, to treat respiratory conditions. It is specifically designed for patients with asthma or chronic obstructive pulmonary disease (COPD) to help control symptoms and improve lung function.

Key Benefits & Uses

• Reduces inflammation and airway constriction in asthma patients
• Helps to control COPD symptoms such as wheezing, coughing, and shortness of breath
• Improves lung function and overall quality of life for patients with respiratory conditions

Active Ingredient & Action

SALMETEROL (SALMETEROL XINAFOATE) is a long-acting beta2-adrenergic receptor agonist (LABA) that helps to relax airway muscles, while FLUTICASONE PROPIONATE is an inhaled corticosteroid (ICS) that reduces inflammation in the lungs. Together, they work to prevent bronchospasm and reduce inflammation, making it easier to breathe.

Important Notes

WIXELA INHUB should only be used as directed by a healthcare provider. Patients should not stop using WIXELA INHUB without consulting their doctor, as this can lead to worsening of symptoms. It is also important to rinse the mouth with water after each use to prevent fungal infections. If you experience any side effects or have concerns, consult your healthcare provider for medical advice.